Valuation: Bristol-Myers Squibb Company

Capitalization 95.32B 83.12B 78.08B 71.01B 131B 8,279B 148B 921B 356B 3,772B 358B 350B 13,893B P/E ratio 2025 *
10.4x
P/E ratio 2026 * 9.97x
Enterprise value 128B 111B 105B 95.13B 175B 11,092B 198B 1,234B 477B 5,053B 479B 469B 18,613B EV / Sales 2025 *
2.77x
EV / Sales 2026 * 2.81x
Free-Float
67.93%
Yield 2025 *
5.29%
Yield 2026 * 5.47%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.83%
1 week-7.60%
Current month-2.98%
1 month-0.80%
3 months-22.04%
6 months-16.80%
Current year-17.19%
More quotes
1 week 46.39
Extreme 46.39
49.44
1 month 46.1
Extreme 46.1
50.76
Current year 44
Extreme 44
63.33
1 year 39.35
Extreme 39.35
63.33
3 years 39.35
Extreme 39.35
81.44
5 years 39.35
Extreme 39.35
81.44
10 years 39.35
Extreme 39.35
81.44
More quotes
Manager TitleAgeSince
Chief Executive Officer 54 2023-10-31
Director of Finance/CFO 57 2019-11-19
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 54 2024-03-31
Director/Board Member 60 2016-03-31
Director/Board Member 70 2017-02-20
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.83%-7.60%+14.78%-36.51% 95.32B
-0.78%-3.33%-11.94%+169.86% 705B
-1.08%-3.79%+3.49%-11.05% 363B
+1.22%-5.93%-50.38%+30.75% 331B
+0.01%-3.60%+8.25%+34.14% 328B
+0.35%-4.62%+4.08%-14.29% 254B
+0.25%-2.92%+1.37%+20.55% 228B
+0.04%-4.33%-14.49%+6.33% 220B
+1.29%-3.09%-38.05%-6.30% 199B
-0.19%-2.62%-5.39%+23.34% 156B
Average +0.03%-3.47%-8.83%+21.68% 287.87B
Weighted average by Cap. -0.08%-3.40%-10.41%+48.08%
See all sector performances

Financials

2025 *2026 *
Net sales 46.16B 40.25B 37.81B 34.39B 63.41B 4,010B 71.53B 446B 172B 1,827B 173B 170B 6,728B 42.98B 37.48B 35.21B 32.02B 59.04B 3,733B 66.6B 415B 160B 1,701B 161B 158B 6,264B
Net income 8.87B 7.73B 7.26B 6.61B 12.18B 770B 13.74B 85.69B 33.09B 351B 33.28B 32.56B 1,292B 9.61B 8.38B 7.87B 7.16B 13.2B 834B 14.89B 92.85B 35.85B 380B 36.05B 35.28B 1,400B
Net Debt 32.39B 28.24B 26.53B 24.12B 44.49B 2,813B 50.18B 313B 121B 1,281B 122B 119B 4,720B 25.64B 22.35B 21B 19.1B 35.21B 2,227B 39.72B 248B 95.65B 1,014B 96.2B 94.15B 3,736B
More financial data * Estimated data
Logo Bristol-Myers Squibb Company
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Employees
34,100
More about the company
Date Price Change Volume
25-06-18 46.84 $ -0.83% 15,864,156
25-06-17 47.23 $ -2.94% 12,453,785
25-06-16 48.66 $ -2.19% 14,974,438
25-06-13 49.75 $ -1.85% 9,499,414
25-06-12 50.69 $ +1.06% 9,620,449

Delayed Quote Nyse, June 18, 2025 at 04:10 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
27
Last Close Price
46.84USD
Average target price
57.10USD
Spread / Average Target
+21.90%
Consensus

Quarterly revenue - Rate of surprise